Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Monitoring for adverse effects in clinical treatments is crucial.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Minoxidil-coated microbubbles with sonication effectively enhance hair growth.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Innovative methods are reducing animal testing and improving biomedical research.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.